PALB2-Related Cancer Predisposition: A Patient Guide

A diagnosis of PALB2-related cancer predisposition means that you carry a change in a gene responsible for protecting your body against cancer. It is important to understand that this result means you have an increased risk of developing certain cancers; it is not a cancer diagnosis itself.

Note: This guide focuses on inherited (germline) predisposition. If your PALB2 finding was discovered only in a tumor (somatic testing), or if you were told you have a Variant of Uncertain Significance (VUS), you should discuss with your care team how that differs from a confirmed inherited pathogenic variant.

PALB2 acts as a critical biological bridge, connecting two other well-known proteins, BRCA1 and BRCA2, to form a repair crew that fixes damage to your DNA ^[1]. When this bridge is not functioning properly, the repair crew cannot coordinate effectively, allowing DNA errors to accumulate over time. While this increases the likelihood of certain cancers developing, it also provides a framework for your medical team to monitor your health ^[2][3].

The primary risks associated with a PALB2 mutation involve cancers of the breast (in both women and men), ovaries, and pancreas ^[2]. Because these risks are now known, your healthcare shifts from general wellness to a strategy of proactive surveillance. This typically involves specialized imaging, such as breast MRIs and high-resolution mammography, designed to catch any changes at the earliest stages ^[4][5]. For some, this journey may also include complex, shared decisions about risk-reducing surgeries, such as mastectomy or the removal of the ovaries and fallopian tubes. These are deeply personal choices made alongside your doctors, weighing your individual risk factors against your long-term quality of life ^[6][7].

Should cancer ever develop, your PALB2 status may provide useful treatment information. Because the mutation affects how cancer cells repair themselves, it can open the door to targeted therapies, such as PARP inhibitors or platinum chemotherapy, depending on the specific tumor type and stage ^[8]. While these treatments come with side effects and are not guaranteed cures, they offer additional options for your oncology team ^[9][10].

Finally, understanding your PALB2 status is a vital piece of information for your family. Each of your children has a 50% chance of inheriting this mutation, and it is a recommended option for reproductive partners to be tested to understand the risk of Fanconi Anemia Type N, a rare and serious childhood condition that can occur if a child inherits mutations from both parents ^[10][11].

Managing a hereditary cancer risk can be emotionally taxing. Seeking emotional support, whether through counseling or a hereditary-cancer support group, is a normal and important part of your ongoing care ^[3].